Squamous Non-Small Cell Lung Cancer Therapeutics Market Analysis by 2025: Top Players Like MacroGenics, Inc, Bayer AG, Novartis AG, Genentech
The Top key vendors in Squamous Non-Small Cell Lung Cancer Therapeutics Market include are Ascenta Therapeutics, Inc., AstraZeneca Plc, AVEO Pharmaceuticals, Inc., Bayer AG, BIND Therapeutics, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Five Prime Therapeutics, Inc., Genentech, Inc., Incyte Corporation, Johnson & Johnson, MacroGenics, Inc., Novartis AG, Oncogenex Pharmaceuticals, Inc., PsiOxus Therapeutics Limited.
View full press release